시장보고서

상품코드

1584113

E형 간염 진단 검사 시장 : 제품 유형별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Hepatitis E Diagnostic Tests Market, By Product Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 10월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

E형 간염 진단 검사 시장 규모는 2023년에 5,352만 달러에 달하며, 2024-2032년 CAGR 4.80%로 확대

E형 간염 진단 검사 시장 - 시장 역학

조기진단과 시기적절한 치료 요구의 증가가 시장 수요를 촉진

세계 E형 간염 진단 테스트 시장은 최근 수년간 상당한 기술 발전으로 진단 솔루션의 정확성, 효율성 및 접근성이 향상되고 있습니다. 예를 들어 DiaSorin은 2021년 6월 E형 간염 진단을 위한 완전 자동화된 고처리량 CLIA 솔루션을 출시하여 CE 마크를 승인한 국가에서 사용할 수 있게 되었습니다. 이 새로운 솔루션은 E형 간염 진단의 중요한 개선 사항으로, 의료 서비스 프로바이더가 고처리량 검사를 효율적으로 수행할 수 있도록 지원합니다. 이 기능은 E형 간염 유병률이 높은 지역에서 특히 중요하며, 감염자의 신속한 식별은 효과적인 질병 관리 및 예방에 필수적입니다. 이러한 첨단 진단 플랫폼의 도입은 정확하고 효율적인 검사 솔루션에 대한 수요 증가에 부응하는 것입니다. 의료 서비스 프로바이더, 위험에 처한 사람들, 일반 대중의 인식 제고 노력도 시장 성장을 가속하는 데 있으며, 매우 중요합니다. 임산부 사망률 증가 등 E형 간염의 위험과 결과에 대한 인식이 높아지면서 정확한 진단 검사에 대한 수요가 증가하고 있으며, WHO의 2023년 필수 진단 의약품 리스트에 E형 간염 검사가 포함된 것은 E형 간염의 조기 발견과 관리의 중요성에 대한 전 세계적인 인식이 높아졌습니다는 것을 보여줍니다. 강조하고 있습니다. 각국 정부와 의료 시스템은 감시 및 발병 관리 개선의 필요성을 점점 더 인식하고 있으며, 이는 HEV 진단키트 조달 확대에 영향을 미치고 있습니다. 또한 환자와 임상의들은 조기 진단과 적시 치료를 위한 E형 간염 검사에 대한 접근성 향상을 요구하고 있으며, 이는 시장 성장을 더욱 촉진하고 있습니다. 예를 들어 인도 정부의 종합적인 국가 바이러스성 간염 퇴치 프로그램은 예방, 진단 및 치료에 초점을 맞춘 다각적인 접근 방식을 통해 E형 간염을 포함한 모든 형태의 바이러스성 간염 부담을 해결하는 것을 목표로 하고 있습니다. 이 프로그램은 바이러스성 간염을 효과적으로 관리할 수 있는 의료 시스템의 역량을 강화하기 위해 막대한 정부 자금과 분권화된 실행 전략을 활용하고 있습니다. 특히 신흥 시장에서의 의료비 지출 증가도 시장 성장을 지원하고 있습니다. E형 간염에 대한 인식이 높아짐에 따라 개인 위생, 안전한 수자원, 적절한 위생 관리, 식품 안전과 같은 예방 조치에 중점을 두어 바이러스의 확산을 완화하는 데 중점을 두고 있습니다. 예방 조치를 시행하는 데에 중점을 두고 있습니다.

E형 간염 진단 검사 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 4.80%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

제품 유형별로는 ELISA HEV IgM 검사가 22023년 가장 높은 시장 점유율을 차지했습니다.

최종 용도별로는 2023년 병원이 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 주요 수입원으로 부상했습니다.

E형 간염 진단 검사 시장 - 세분화 분석 :

세계 E형 간염 진단 테스트 시장은 제품 유형, 최종 용도 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 ELISA HEV IgM 검사, ELISA HEV IgG 검사, 신속 진단 검사, 중합효소 연쇄반응(PCR) 등 4가지 범주로 나뉩니다. 유형별로는 ELISA HEV IgM 검사 부문이 2023년 가장 큰 매출 점유율로 E형 간염 진단 검사 시장을 주도했습니다. 이러한 우위는 주로 급성 또는 최근(6개월 미만) 감염을 식별하기 위해 E형 간염 바이러스(HEV)에 대한 IgM 클래스 항체를 검출하는 중요한 역할에 기인하며, IgM 항체의 존재는 급성 E형 간염 진단에 필수적이며, 일반적으로 추적 RNA 검사를 통해 확인됩니다. ELISA 기반 IgM 검사는 민감도와 특이도가 높기 때문에 HEV의 초기 선별 검사에 적합합니다. 예를 들어 Dia.Pro는 인간 혈청 또는 혈장에서 HEV에 대한 IgM 항체를 검출하기 위해 특별히 설계된 HEV-IgM ELISA 테스트 키트를 제공합니다. 특히 위생 환경이 열악한 개발도상국에서 E형 간염 감염이 증가함에 따라 ELISA HEV IgM 검사와 같은 효과적인 진단 툴에 대한 수요가 크게 증가하고 있습니다.

시장은 최종 용도에 따라 병원, 혈액은행, 진단 실험실, 기타 최종 용도 등 4가지 범주로 나뉩니다. 최종 용도별로는 병원 부문이 2023년 가장 큰 매출 점유율을 차지하며 시장을 주도할 것으로 예상됩니다. 이러한 추세는 주로 전 세계에서 병원에서 진단 및 치료를 받는 E형 간염 환자의 높은 유병률에 기인합니다. 병원은 고급 진단 장비, 다양한 의료 전문가, E형 간염 환자를 효율적으로 진단하고 관리하는 데 필요한 인프라를 갖추고 있습니다. 또한 병원은 종종 더 복잡한 사례의 의뢰 센터 역할을 하는 경우가 많으며, 이는 세계 시장에서 더 큰 매출 점유율을 차지하게 됩니다.

E형 간염 진단 검사 시장 - 지역적 인사이트

이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카 등 지역적으로 분산된 고객층을 대상으로 하고 있습니다. 이들 지역내 진입 업체들이 시장의 하위 부문을 형성하고 있습니다. 북미 E형 간염 진단 테스트 시장은 2023년 큰 점유율을 차지했습니다. 이 지역은 병원, 진단 실험실 및 연구센터로 구성된 의료 인프라가 잘 구축되어 있으며, 진단 테스트 채택에 적합한 환경을 제공함으로써 시장 성장을 지원하고 있습니다. 또한 감염성 질환 진단 연구개발에 대한 정부의 구상과 자금 지원은 새로운 진단 솔루션의 개발 및 채택을 촉진하여 시장 성장에 기여하고 있습니다. 예를 들어 2024년 4월 미네소타 대학교 호멜 연구소의 Susan Hafenstein 박사는 Nationwide Children's Hospital로부터 85,000달러의 NIH 보조금을 지원받아 E형 간염의 새로운 치료 및 예방 전략을 창출하기 위한 HEV의 E형 간염의 새로운 치료 및 예방 전략을 개발하기 위한 저온 전자현미경 연구를 지원했습니다.

E형 간염 진단 검사 시장 - 경쟁 구도 :

E형 간염 진단 검사 시장의 업체들은 경쟁력을 강화하고 시장 범위를 확대하기 위해 다양한 전략을 채택하고 있습니다. 연구개발에 중점을 두는 것은 매우 중요하며, 검사 민감도와 특이도를 개선하고 신속하고 신속한 현장 검사 솔루션을 개발하는 데 주력하고 있습니다. 의료 기관 및 검사 시설과의 전략적 협력 관계는 임상 검증을 촉진하고 새로운 검사의 보급을 촉진합니다. 마케팅 전략은 합병증 예방에 있으며, 조기 발견의 중요성을 강조하며, 특히 의료 서비스 프로바이더 및 공중 보건 기관을 대상으로 합니다. 또한 각 회사는 E형 간염의 위험과 검사 가능성에 대한 인식을 높이기 위해 교육적 노력을 기울이고 있으며, 간 헬스케어에 필수적인 진단 약품에 대한 인식을 높이기 위해 자주 노력하고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제10장 주요 벤더 분석 - E형 간염 진단 검사 업계

경쟁 대시보드
기업 개요
- Altona Diagnostics
- Dia.Pro Diagnostic Bioprobes srl
- ELITechGroup
- F. Hoffmann-La Roche Ltd
- Fortress Diagnostics
- Mikrogen GmbH
- MP Biomedicals LLP
- PerkinElmer, Inc
- Primerdesign Ltd
- Wantai BioPharm
- Others

제11장 애널리스트의 전방위 전망

KSA 24.11.14

REPORT HIGHLIGHT

Hepatitis E Diagnostic Tests Market size was valued at USD 53.52 Million in 2023, expanding at a CAGR of 4.80% from 2024 to 2032.

Hepatitis E diagnostic tests are medical assays designed to detect the presence of the Hepatitis E virus (HEV), which causes liver inflammation. These tests typically utilize serological methods to identify antibodies (anti-HEV IgM and IgG) or molecular techniques such as PCR polymerase chain reaction (PCR) to detect viral RNA. Early and accurate diagnosis is crucial for managing hepatitis E, especially in pregnant women and individuals with compromised liver function, as the infection can result in severe complications. Hepatitis E diagnostics play a vital role in public health monitoring and controlling outbreaks, particularly in regions where the virus is endemic.

Hepatitis E Diagnostic Tests Market- Market Dynamics

Increasing need of early diagnosis and timely treatment to propel market demand

The global market for hepatitis E diagnostics has experienced significant technological advancements in recent years, enhancing the accuracy, efficiency, and accessibility of diagnostic solutions. For instance, in June 2021, DiaSorin launched fully automated high-throughput CLIA solution for the hepatitis E diagnosis, available in countries that accept the CE mark. This new offering represents a important improvement in hepatitis E diagnostics, allowing healthcare providers to conduct high-throughput testing efficiently. This capability is particularly important in regions with high hepatitis E prevalence, where rapid identification of infected individuals is essential for effective disease management and prevention. The introduction of such advanced diagnostic platforms meets the growing demand for accurate and efficient testing solutions. Efforts to raise awareness among healthcare providers, at-risk populations, and the general public are also crucial in driving market growth. Increased awareness of the risks and consequences of hepatitis E, including higher mortality rates in pregnant women, is fueling demand for accurate diagnostic tests. The inclusion of hepatitis E tests in the WHO's 2023 Essential Diagnostics List highlights the global recognition of the importance of early detection and management of the disease. Governments and healthcare systems are increasingly acknowledging the need for improved surveillance and outbreak management, leading to greater procurement of HEV diagnostic kits. Additionally, patients and clinicians are seeking better access to hepatitis E tests to enable early diagnosis and timely treatment, further boosting market growth. For example, the Government of India's comprehensive National Viral Hepatitis Control Program aims to address the burden of all forms of viral hepatitis, including hepatitis E, through a multi-pronged approach focused on prevention, diagnosis, and treatment. This program involves significant government funding and a decentralized implementation strategy to enhance the healthcare system's capacity to manage viral hepatitis effectively. Increasing healthcare expenditure, particularly in emerging markets, is also supporting market growth. The emphasis on early detection and effective disease management is driving demand for diagnostic tests. As awareness about hepatitis E grows, there is a heightened focus on implementing preventive measures, including personal hygiene, safe water sources, proper sanitation, and food safety, to mitigate the virus's spread.

Hepatitis E Diagnostic Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.80% over the forecast period (2024-2032)

Based on Product Type segmentation, ELISA HEV IgM test was predicted to show maximum market share in the year 2023

Based on End-use segmentation, the hospital was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Hepatitis E Diagnostic Tests Market- Segmentation Analysis:

The Global Hepatitis E Diagnostic Tests Market is segmented on the basis of Product Type, End-use, and Region.

The market is divided into four categories based on product type: ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test and Polymerase Chain Reaction (PCR). Based on type, the ELISA HEV IgM test segment led the hepatitis E diagnostic tests market with the largest revenue share in 2023. This dominance is primarily due to the critical role of detecting IgM-class antibodies to the hepatitis E virus (HEV) for identifying acute or recent infections (less than six months). The presence of IgM antibodies is essential for diagnosing acute hepatitis E, typically confirmed by follow-up RNA testing. The high sensitivity and specificity of ELISA-based IgM tests make them the preferred option for initial HEV screening. For example, Dia.Pro offers the HEV-IgM ELISA test kit, specifically designed to detect IgM antibodies against HEV in human serum or plasma. The increasing incidence of hepatitis E infections, especially in developing regions with inadequate sanitation and hygiene practices, has significantly boosted the demand for effective diagnostic tools like the ELISA HEV IgM test.

The market is divided into four categories based on End use: Hospital, Blood Banks, Diagnostics Laboratories, and Other End User. In terms of end use, the hospital segment was leading the market with the largest revenue share in 2023. This trend is primarily driven by the high prevalence of hepatitis E cases being diagnosed and treated in hospitals globally. Hospitals are equipped with advanced diagnostic facilities, a diverse range of healthcare professionals, and the necessary infrastructure to efficiently diagnose and manage hepatitis E cases. Moreover, hospitals often act as referral centers for more complex cases, further enhancing their significant revenue share in the global market.

Hepatitis E Diagnostic Tests Market- Geographical Insights

This market caters to a geographically scattered customer base, spanning North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Participating nations within these regions create sub-segments within the market. The hepatitis E diagnostic tests market in North America accounted for a significant share in 2023. The region's well-established healthcare infrastructure, comprising hospitals, diagnostic laboratories, and research centers, supports market growth by providing a conducive environment for the adoption of diagnostic tests. Additionally, government initiatives and funding for research and development in infectious disease diagnostics contribute to market growth by facilitating the development and adoption of new diagnostic solutions. For instance, in April 2024, Dr. Susan Hafenstein of The Hormel Institute at the University of Minnesota received an $85,000 NIH-funded grant from Nationwide Children's Hospital to support her cryoEM research into HEV, with the goal of creating new treatments and prevention strategies for hepatitis E.

Hepatitis E Diagnostic Tests Market- Competitive Landscape:

Companies in the hepatitis E diagnostic tests market employ various strategies to enhance competitiveness and expand their market reach. Emphasizing research and development is crucial, with efforts focused on improving test sensitivity and specificity, as well as creating rapid and point-of-care testing solutions. Strategic collaborations with healthcare institutions and laboratories help facilitate clinical validation and promote the widespread adoption of new tests. Marketing strategies highlight the importance of early detection in preventing complications, specifically targeting healthcare providers and public health agencies. Additionally, companies frequently engage in educational initiatives to raise awareness about the risks of hepatitis E and the availability of testing, ensuring that diagnostics become an integral part of liver health management.

Recent Developments:

In November 2023, Roche introduced two automated immunoassays, the Elecsys Anti-HEV IgG and the Elecsys Anti-HEV IgM, designed to detect hepatitis E virus infections. These tests are available in countries that recognize the CE mark, including members of the European Union.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Altona Diagnostics
Dia.Pro Diagnostic Bioprobes srl
ELITechGroup
F. Hoffmann-La Roche Ltd
Fortress Diagnostics
Mikrogen GmbH
MP Biomedicals LLP
PerkinElmer, Inc
Primerdesign Ltd
Wantai BioPharm
Others

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

ELISA HEV IgM Test
ELISA HEV IgG Test
Rapid Diagnostics Test
Polymerase Chain Reaction (PCR)

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospital
Diagnostics Laboratories
Blood Banks
Other End User

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Hepatitis E Diagnostic Tests Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Hepatitis E Diagnostic Tests Market Snippet by Product Type
- 2.1.2. Hepatitis E Diagnostic Tests Market Snippet by End Use
- 2.1.3. Hepatitis E Diagnostic Tests Market Snippet by Country
- 2.1.4. Hepatitis E Diagnostic Tests Market Snippet by Region
2.2. Competitive Insights

3. Hepatitis E Diagnostic Tests Key Market Trends

3.1. Hepatitis E Diagnostic Tests Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Hepatitis E Diagnostic Tests Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Hepatitis E Diagnostic Tests Market Opportunities
3.4. Hepatitis E Diagnostic Tests Market Future Trends

4. Hepatitis E Diagnostic Tests Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Hepatitis E Diagnostic Tests Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Hepatitis E Diagnostic Tests Market Landscape

6.1. Hepatitis E Diagnostic Tests Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Hepatitis E Diagnostic Tests Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2. ELISA HEV IgM Test
- 7.1.3. ELISA HEV IgG Test
- 7.1.4. Rapid Diagnostics Test
- 7.1.5. Polymerase Chain Reaction (PCR)

8. Hepatitis E Diagnostic Tests Market - By End Use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
- 8.1.2. Hospital
- 8.1.3. Diagnostics Laboratories
- 8.1.4. Blood Banks
- 8.1.5. Other End User

9. Hepatitis E Diagnostic Tests Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Hepatitis E Diagnostic Tests Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Hepatitis E Diagnostic Tests Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.7. Italy
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.8. United Kingdom
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.9. France
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.10. Russia
  - 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.10.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.11. Netherlands
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.12. Sweden
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.13. Poland
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.14. Rest of Europe
  - 9.3.14.1. Overview
  - 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.14.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Hepatitis E Diagnostic Tests Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.8. Japan
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.9. South Korea
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Hepatitis E Diagnostic Tests Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Hepatitis E Diagnostic Tests Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hepatitis E Diagnostic Tests Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Altona Diagnostics
- 10.2.2. Dia.Pro Diagnostic Bioprobes srl
- 10.2.3. ELITechGroup
- 10.2.4. F. Hoffmann-La Roche Ltd
- 10.2.5. Fortress Diagnostics
- 10.2.6. Mikrogen GmbH
- 10.2.7. MP Biomedicals LLP
- 10.2.8. PerkinElmer, Inc
- 10.2.9. Primerdesign Ltd
- 10.2.10. Wantai BioPharm
- 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us